Our study revealed that TRIB3 induced by ATRA/arsenic therapy further inhibits PPARγ activity to dysregulate TG and adipocytokine secretion in APL cells, which subsequently contributes to the disordered lipid metabolism associated with APL. The gene discussed is PPARG; the disease is acute promyelocytic leukemia.